In November, we announced plans to build a new $3 billion manufacturing facility in Leiden, Netherlands, located within the Leiden Bio Science Park. This major project will expand Lilly's capacity to produce oral medicines and strengthen the company's global supply chain. The facility will incorporate advanced manufacturing technologies to meet the needs of Lilly's growing portfolio of oral solid medicines in cardiometabolic health, neuroscience, oncology and immunology.
Lilly in The Netherlands
Loading...
Working to help people live healthier requires investing in the future of medicine making.
